Review





Similar Products

99
Cell Signaling Technology Inc anti erk1 2 rabbit mab
Anti Erk1 2 Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk1+2/p44%2F42+MAPK+(Erk1%2F2)+Rabbit+mAb/pmc13768825-116-72-76
Average 99 stars, based on 1 article reviews
anti erk1 2 rabbit mab - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc α sma
ATL-III attenuates TGF-β1-induced myofibroblast differentiation in primary human corneal keratocytes . Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 48 h. ( a ) Representative immunofluorescence images of <t>α-SMA</t> (red), F-actin stained with phalloidin (green), and nuclei counterstained with DAPI (blue), with merged images shown in the right column. Experimental groups are arranged from top to bottom as untreated control (CTL), TGF-β1, TGF-β1 + ATL-III 50 µM, and TGF-β1 + ATL-III 100 µM. Images were acquired using identical acquisition settings across all experimental groups. Scale bar = 100 µm. ( b ) Representative Western blot images of α-SMA and GAPDH together with densitometric analysis of α-SMA protein expression normalized to GAPDH and expressed relative to the untreated control group. n = 3 independent experiments. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s multiple-comparison test. * p < 0.05 and ** p < 0.01.
α Sma, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk1+2/p44%2F42+MAPK+(Erk1%2F2)+Antibody/pmc13765516-160-76-77
Average 99 stars, based on 1 article reviews
α sma - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc phospho erk1 2
Effects of ATL-III on TGF-β1-induced intracellular signaling in primary human corneal keratocytes. Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 1 h. Representative Western blot images and corresponding densitometric analyses are shown for ( a ) phosphorylated SMAD2/3 (p-SMAD2/3) and total SMAD2/3, ( b ) phosphorylated p38 MAPK (p-p38 MAPK) and total p38 MAPK, ( c ) phosphorylated AMPK (p-AMPK) and total AMPK, ( d ) <t>phosphorylated</t> <t>ERK1/2</t> (p-ERK1/2) and total ERK1/2, and ( e ) phosphorylated NF-κB (p-NF-κB) and total NF-κB. Phosphorylated protein levels were normalized to their corresponding total protein levels and expressed relative to the untreated control group. n = 3 independent experiments. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple-comparison test, with the TGF-β1-treated group used as the reference group for treatment comparisons. * p < 0.05, ** p < 0.01, and **** p < 0.0001.
Phospho Erk1 2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk1+2/Phospho-p44%2F42+MAPK+(Erk1%2F2)+(Thr202%2FTyr204)+Antibody/pmc13765516-160-66-67
Average 99 stars, based on 1 article reviews
phospho erk1 2 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc anti phospho p44 42 mapk antibody
Effects of ATL-III on TGF-β1-induced intracellular signaling in primary human corneal keratocytes. Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 1 h. Representative Western blot images and corresponding densitometric analyses are shown for ( a ) phosphorylated SMAD2/3 (p-SMAD2/3) and total SMAD2/3, ( b ) phosphorylated p38 MAPK (p-p38 MAPK) and total p38 MAPK, ( c ) phosphorylated AMPK (p-AMPK) and total AMPK, ( d ) <t>phosphorylated</t> <t>ERK1/2</t> (p-ERK1/2) and total ERK1/2, and ( e ) phosphorylated NF-κB (p-NF-κB) and total NF-κB. Phosphorylated protein levels were normalized to their corresponding total protein levels and expressed relative to the untreated control group. n = 3 independent experiments. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple-comparison test, with the TGF-β1-treated group used as the reference group for treatment comparisons. * p < 0.05, ** p < 0.01, and **** p < 0.0001.
Anti Phospho P44 42 Mapk Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk1+2/Phospho-p44%2F42+MAPK+(Erk1%2F2)+(Thr202%2FTyr204)+Antibody/pm42989802-297-10-17
Average 99 stars, based on 1 article reviews
anti phospho p44 42 mapk antibody - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc mouse anti phospho mapk
Effects of ATL-III on TGF-β1-induced intracellular signaling in primary human corneal keratocytes. Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 1 h. Representative Western blot images and corresponding densitometric analyses are shown for ( a ) phosphorylated SMAD2/3 (p-SMAD2/3) and total SMAD2/3, ( b ) phosphorylated p38 MAPK (p-p38 MAPK) and total p38 MAPK, ( c ) phosphorylated AMPK (p-AMPK) and total AMPK, ( d ) <t>phosphorylated</t> <t>ERK1/2</t> (p-ERK1/2) and total ERK1/2, and ( e ) phosphorylated NF-κB (p-NF-κB) and total NF-κB. Phosphorylated protein levels were normalized to their corresponding total protein levels and expressed relative to the untreated control group. n = 3 independent experiments. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple-comparison test, with the TGF-β1-treated group used as the reference group for treatment comparisons. * p < 0.05, ** p < 0.01, and **** p < 0.0001.
Mouse Anti Phospho Mapk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk1+2/Phospho-p44%2F42+MAPK+(Erk1%2F2)+(Thr202%2FTyr204)+Mouse+mAb/pm42986876-140-43-45
Average 96 stars, based on 1 article reviews
mouse anti phospho mapk - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc phospho erk1 2 thr202 tyr204
Effects of ATL-III on TGF-β1-induced intracellular signaling in primary human corneal keratocytes. Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 1 h. Representative Western blot images and corresponding densitometric analyses are shown for ( a ) phosphorylated SMAD2/3 (p-SMAD2/3) and total SMAD2/3, ( b ) phosphorylated p38 MAPK (p-p38 MAPK) and total p38 MAPK, ( c ) phosphorylated AMPK (p-AMPK) and total AMPK, ( d ) <t>phosphorylated</t> <t>ERK1/2</t> (p-ERK1/2) and total ERK1/2, and ( e ) phosphorylated NF-κB (p-NF-κB) and total NF-κB. Phosphorylated protein levels were normalized to their corresponding total protein levels and expressed relative to the untreated control group. n = 3 independent experiments. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple-comparison test, with the TGF-β1-treated group used as the reference group for treatment comparisons. * p < 0.05, ** p < 0.01, and **** p < 0.0001.
Phospho Erk1 2 Thr202 Tyr204, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk1+2/Ki-67+Rabbit+mAb/10__1158_slash_2767___9764__crc___26___0581-121-36-38
Average 96 stars, based on 1 article reviews
phospho erk1 2 thr202 tyr204 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc erk1 2
Effects of ATL-III on TGF-β1-induced intracellular signaling in primary human corneal keratocytes. Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 1 h. Representative Western blot images and corresponding densitometric analyses are shown for ( a ) phosphorylated SMAD2/3 (p-SMAD2/3) and total SMAD2/3, ( b ) phosphorylated p38 MAPK (p-p38 MAPK) and total p38 MAPK, ( c ) phosphorylated AMPK (p-AMPK) and total AMPK, ( d ) <t>phosphorylated</t> <t>ERK1/2</t> (p-ERK1/2) and total ERK1/2, and ( e ) phosphorylated NF-κB (p-NF-κB) and total NF-κB. Phosphorylated protein levels were normalized to their corresponding total protein levels and expressed relative to the untreated control group. n = 3 independent experiments. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple-comparison test, with the TGF-β1-treated group used as the reference group for treatment comparisons. * p < 0.05, ** p < 0.01, and **** p < 0.0001.
Erk1 2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk1+2/p44%2F42+MAPK+(Erk1%2F2)+Rabbit+mAb/pm42988024-87-13-6
Average 99 stars, based on 1 article reviews
erk1 2 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc p erk1 2
Effects of ATL-III on TGF-β1-induced intracellular signaling in primary human corneal keratocytes. Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 1 h. Representative Western blot images and corresponding densitometric analyses are shown for ( a ) phosphorylated SMAD2/3 (p-SMAD2/3) and total SMAD2/3, ( b ) phosphorylated p38 MAPK (p-p38 MAPK) and total p38 MAPK, ( c ) phosphorylated AMPK (p-AMPK) and total AMPK, ( d ) <t>phosphorylated</t> <t>ERK1/2</t> (p-ERK1/2) and total ERK1/2, and ( e ) phosphorylated NF-κB (p-NF-κB) and total NF-κB. Phosphorylated protein levels were normalized to their corresponding total protein levels and expressed relative to the untreated control group. n = 3 independent experiments. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple-comparison test, with the TGF-β1-treated group used as the reference group for treatment comparisons. * p < 0.05, ** p < 0.01, and **** p < 0.0001.
P Erk1 2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk1+2/Phospho-p44%2F42+MAPK+(Erk1%2F2)+(Thr202%2FTyr204)+XP+Rabbit+mAb/pm42988024-87-15-6
Average 99 stars, based on 1 article reviews
p erk1 2 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc phospho p44 42 mapk
Effects of ATL-III on TGF-β1-induced intracellular signaling in primary human corneal keratocytes. Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 1 h. Representative Western blot images and corresponding densitometric analyses are shown for ( a ) phosphorylated SMAD2/3 (p-SMAD2/3) and total SMAD2/3, ( b ) phosphorylated p38 MAPK (p-p38 MAPK) and total p38 MAPK, ( c ) phosphorylated AMPK (p-AMPK) and total AMPK, ( d ) <t>phosphorylated</t> <t>ERK1/2</t> (p-ERK1/2) and total ERK1/2, and ( e ) phosphorylated NF-κB (p-NF-κB) and total NF-κB. Phosphorylated protein levels were normalized to their corresponding total protein levels and expressed relative to the untreated control group. n = 3 independent experiments. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple-comparison test, with the TGF-β1-treated group used as the reference group for treatment comparisons. * p < 0.05, ** p < 0.01, and **** p < 0.0001.
Phospho P44 42 Mapk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk1+2/Phospho-p44%2F42+MAPK+(Erk1%2F2)+(Thr202%2FTyr204)+Antibody/pmc13763638-183-54-58
Average 99 stars, based on 1 article reviews
phospho p44 42 mapk - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

Image Search Results


ATL-III attenuates TGF-β1-induced myofibroblast differentiation in primary human corneal keratocytes . Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 48 h. ( a ) Representative immunofluorescence images of α-SMA (red), F-actin stained with phalloidin (green), and nuclei counterstained with DAPI (blue), with merged images shown in the right column. Experimental groups are arranged from top to bottom as untreated control (CTL), TGF-β1, TGF-β1 + ATL-III 50 µM, and TGF-β1 + ATL-III 100 µM. Images were acquired using identical acquisition settings across all experimental groups. Scale bar = 100 µm. ( b ) Representative Western blot images of α-SMA and GAPDH together with densitometric analysis of α-SMA protein expression normalized to GAPDH and expressed relative to the untreated control group. n = 3 independent experiments. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s multiple-comparison test. * p < 0.05 and ** p < 0.01.

Journal: Molecules

Article Title: Atractylenolide III Attenuates TGF-β1-Induced Myofibroblast Differentiation in Primary Human Corneal Keratocytes

doi: 10.3390/molecules31214040

Figure Lengend Snippet: ATL-III attenuates TGF-β1-induced myofibroblast differentiation in primary human corneal keratocytes . Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 48 h. ( a ) Representative immunofluorescence images of α-SMA (red), F-actin stained with phalloidin (green), and nuclei counterstained with DAPI (blue), with merged images shown in the right column. Experimental groups are arranged from top to bottom as untreated control (CTL), TGF-β1, TGF-β1 + ATL-III 50 µM, and TGF-β1 + ATL-III 100 µM. Images were acquired using identical acquisition settings across all experimental groups. Scale bar = 100 µm. ( b ) Representative Western blot images of α-SMA and GAPDH together with densitometric analysis of α-SMA protein expression normalized to GAPDH and expressed relative to the untreated control group. n = 3 independent experiments. Data are presented as mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey’s multiple-comparison test. * p < 0.05 and ** p < 0.01.

Article Snippet: Following transfer, membranes were blocked with 5% BSA for 30 min and incubated overnight at 4 °C with primary antibodies against the following proteins: phospho-SMAD2/3 (Cellsignaling, catalog no. 8828), SMAD2/3 (Cellsignaling, catalog no. 3102), phospho-AMPK (Cellsignaling, catalog no. 2531), AMPK (Cellsignaling, catalog no. 2532), phospho-NF-κB (Cellsignaling, catalog no. 3033), NF-κB (Cellsignaling, catalog no. 8242), phospho-p38 MAPK (Cellsignaling, catalog no. 9211), p38 MAPK (Cellsignaling, catalog no. 9212), phospho-ERK1/2 (Cellsignaling, catalog no. 9101), ERK1/2 (Cellsignaling, catalog no. 9102), α-SMA (Cellsignaling, catalog no. 14968), GAPDH (Cellsignaling, catalog no. 5174).

Techniques: Immunofluorescence, Staining, Control, Western Blot, Analysis, Expressing, Comparison

Effects of ATL-III on TGF-β1-induced intracellular signaling in primary human corneal keratocytes. Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 1 h. Representative Western blot images and corresponding densitometric analyses are shown for ( a ) phosphorylated SMAD2/3 (p-SMAD2/3) and total SMAD2/3, ( b ) phosphorylated p38 MAPK (p-p38 MAPK) and total p38 MAPK, ( c ) phosphorylated AMPK (p-AMPK) and total AMPK, ( d ) phosphorylated ERK1/2 (p-ERK1/2) and total ERK1/2, and ( e ) phosphorylated NF-κB (p-NF-κB) and total NF-κB. Phosphorylated protein levels were normalized to their corresponding total protein levels and expressed relative to the untreated control group. n = 3 independent experiments. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple-comparison test, with the TGF-β1-treated group used as the reference group for treatment comparisons. * p < 0.05, ** p < 0.01, and **** p < 0.0001.

Journal: Molecules

Article Title: Atractylenolide III Attenuates TGF-β1-Induced Myofibroblast Differentiation in Primary Human Corneal Keratocytes

doi: 10.3390/molecules31214040

Figure Lengend Snippet: Effects of ATL-III on TGF-β1-induced intracellular signaling in primary human corneal keratocytes. Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 1 h. Representative Western blot images and corresponding densitometric analyses are shown for ( a ) phosphorylated SMAD2/3 (p-SMAD2/3) and total SMAD2/3, ( b ) phosphorylated p38 MAPK (p-p38 MAPK) and total p38 MAPK, ( c ) phosphorylated AMPK (p-AMPK) and total AMPK, ( d ) phosphorylated ERK1/2 (p-ERK1/2) and total ERK1/2, and ( e ) phosphorylated NF-κB (p-NF-κB) and total NF-κB. Phosphorylated protein levels were normalized to their corresponding total protein levels and expressed relative to the untreated control group. n = 3 independent experiments. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple-comparison test, with the TGF-β1-treated group used as the reference group for treatment comparisons. * p < 0.05, ** p < 0.01, and **** p < 0.0001.

Article Snippet: Following transfer, membranes were blocked with 5% BSA for 30 min and incubated overnight at 4 °C with primary antibodies against the following proteins: phospho-SMAD2/3 (Cellsignaling, catalog no. 8828), SMAD2/3 (Cellsignaling, catalog no. 3102), phospho-AMPK (Cellsignaling, catalog no. 2531), AMPK (Cellsignaling, catalog no. 2532), phospho-NF-κB (Cellsignaling, catalog no. 3033), NF-κB (Cellsignaling, catalog no. 8242), phospho-p38 MAPK (Cellsignaling, catalog no. 9211), p38 MAPK (Cellsignaling, catalog no. 9212), phospho-ERK1/2 (Cellsignaling, catalog no. 9101), ERK1/2 (Cellsignaling, catalog no. 9102), α-SMA (Cellsignaling, catalog no. 14968), GAPDH (Cellsignaling, catalog no. 5174).

Techniques: Western Blot, Control, Comparison